These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 2812758

  • 1. [Granulocyte-macrophage progenitor cells in allogenic bone marrow transplantation: correlation of progenitor cell content and regeneration in the graft].
    Gidáli J, Poros A, Harsányi V, Fehér I, Mód A, Hollán Z.
    Orv Hetil; 1989 Oct 15; 130(42):2251-4, 2257. PubMed ID: 2812758
    [Abstract] [Full Text] [Related]

  • 2. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment.
    Douay L, Gorin NC, Mary JY, Lemarie E, Lopez M, Najman A, Stachowiak J, Giarratana MC, Baillou C, Salmon C.
    Exp Hematol; 1986 Jun 15; 14(5):358-65. PubMed ID: 3519263
    [Abstract] [Full Text] [Related]

  • 3. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 15; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 4. Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.
    Rowley SD, Piantadosi S, Marcellus DC, Jones RJ, Davidson NE, Davis JM, Kennedy J, Wiley JM, Wingard JR, Yeager AM.
    Bone Marrow Transplant; 1991 Mar 15; 7(3):183-91. PubMed ID: 2059755
    [Abstract] [Full Text] [Related]

  • 5. Failure of bone marrow cryopreservation in chronic granulocytic leukemia: relation to excessive granulo-macrophagic progenitor pool.
    Douay L, Lopez M, Gorin NC, Nauman A, Giarratana MC, Laporte JP, Stachowiak J, Salmon C, Duhamel G.
    Int J Cell Cloning; 1986 Jul 15; 4(4):250-62. PubMed ID: 2875118
    [Abstract] [Full Text] [Related]

  • 6. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V, Ferguson KF, Heller G, Kernan NA.
    Exp Hematol; 1995 Dec 15; 23(14):1422-30. PubMed ID: 8542927
    [Abstract] [Full Text] [Related]

  • 7. Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells.
    Jones RJ, Wagner JE, Celano P, Zicha MS, Sharkis SJ.
    Nature; 1990 Sep 13; 347(6289):188-9. PubMed ID: 2395470
    [Abstract] [Full Text] [Related]

  • 8. Myeloid progenitor cells (CFU-GM) predict engraftment kinetics in autologous transplantation in children.
    Emminger W, Emminger-Schmidmeier W, Höcker P, Hinterberger W, Gadner H.
    Bone Marrow Transplant; 1989 Jul 13; 4(4):415-20. PubMed ID: 2673462
    [Abstract] [Full Text] [Related]

  • 9. Stem cells from peripheral blood and bone marrow: a comparative evaluation of the hemopoietic potential in the dog.
    Raghavachar A, Prümmer O, Fliedner TM, Calvo W, Steinbach IB.
    Int J Cell Cloning; 1983 Sep 13; 1(4):191-205. PubMed ID: 6366082
    [Abstract] [Full Text] [Related]

  • 10. Prediction of engraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony-forming unit-granulocyte-macrophage, or both?
    Jansen EM, Hanks SG, Terry C, Akard LP, Thompson JM, Dugan MJ, Jansen J.
    Transfusion; 2007 May 13; 47(5):817-23. PubMed ID: 17465946
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M, Couture F, Kovacs M, Saragosa R, McCrae J, Brandwein J, Huebsch L, Beauregard-Zollinger L, Keating A.
    Exp Hematol; 1993 Mar 13; 21(3):405-410. PubMed ID: 8440338
    [Abstract] [Full Text] [Related]

  • 12. Engraftment potential of peripheral and cord blood stem cells evaluated by a long-term culture system.
    Hirao A, Kawano Y, Takaue Y, Suzue T, Abe T, Sato J, Saito S, Okamoto Y, Makimoto A, Kawahito M.
    Exp Hematol; 1994 Jun 13; 22(6):521-6. PubMed ID: 8187849
    [Abstract] [Full Text] [Related]

  • 13. Purification of murine bone-marrow-derived granulocyte-macrophage colony-forming cells.
    Williams DE, Straneva JE, Shen RN, Broxmeyer HE.
    Exp Hematol; 1987 Mar 13; 15(3):243-50. PubMed ID: 3817051
    [Abstract] [Full Text] [Related]

  • 14. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG, Crown JP, Wasserheit C, Kritz A, Wong G, Reich L, Norton L, Moore MA.
    Bone Marrow Transplant; 1994 Dec 13; 14(6):877-84. PubMed ID: 7536069
    [Abstract] [Full Text] [Related]

  • 15. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N, Mohamed R.
    Exp Hematol; 1995 Dec 13; 23(14):1661-6. PubMed ID: 8542962
    [Abstract] [Full Text] [Related]

  • 16. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
    Ratajczak MZ, Ratajczak J, Kuczynski W, Light B, Lusk EJ, Gewirtz AM.
    Exp Hematol; 1993 Dec 13; 21(13):1663-7. PubMed ID: 8243568
    [Abstract] [Full Text] [Related]

  • 17. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood.
    Dahl E, Burroughs J, DeFor T, Verfaillie C, Weisdorf D.
    Bone Marrow Transplant; 2003 Sep 13; 32(6):575-80. PubMed ID: 12953129
    [Abstract] [Full Text] [Related]

  • 18. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY.
    J Immunol; 1986 Jun 15; 136(12):4487-95. PubMed ID: 3086433
    [Abstract] [Full Text] [Related]

  • 19. Fibronectin increases both non-adherent cells and CFU-GM while collagen increases adherent cells in human normal long-term bone marrow cultures.
    Hassan HT, Sadovinkova EYu, Drize NJ, Zander AR, Neth R.
    Haematologia (Budap); 1997 Jun 15; 28(2):77-84. PubMed ID: 9283907
    [Abstract] [Full Text] [Related]

  • 20. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE, Benninger L, Cooper S, Hague N, Benjamin RS, Vadhan-Raj S.
    Exp Hematol; 1995 Apr 15; 23(4):335-40. PubMed ID: 7895781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.